See All Slides - tctmd.com

Slides

Presentation TCT 2013

Case #4: Left Main + Ostial LAD + Ostial LCX (Medina 1,1,1)

Presenter: Afzalur Rahman

October 31, 2013

Presentation TCT 2013

The Evolution of Interventional Translational Science: The Backbone of ALL Current and Future Catheter-Based Therapies

Presenter: Juan Granada

October 31, 2013

Presentation TCT 2013

Mortality Trumps All: Ticagrelor for (Nearly) All!

Presenter: Michel Le May

October 31, 2013

Presentation TCT 2013

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Presenter: Freek Verheugt

October 31, 2013

Presentation TCT 2013

Defining and Measuring Frailty: An Important Assessment Feature of High-Risk TAVR Patients

Presenter: Philip Green

October 31, 2013

Presentation TCT 2013

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Presenter: E. Magnus Ohman

October 31, 2013

Presentation TCT 2013

Basal Stenosis Resistance Index: Background, Physiologic Rationale, and Clinical Data

Presenter: Tim van de Hoef

October 31, 2013

Presentation TCT 2013

Case #1: iFR Case

Presenter: Sayan Sen

October 31, 2013

Presentation TCT 2013

A Patient with a Recent Stent Who is Bleeding

Presenter: Peter Wenaweser

October 31, 2013

Presentation

How New Designs Lead to Improved Clinical Results in TAVR

Presenter: Ganesh Manoharan

October 31, 2013

Advertisement

Slides

Case #4: Left Main + Ostial LAD + Ostial LCX (Medina 1,1,1)

The Evolution of Interventional Translational Science: The Backbone of ALL Current and Future Catheter-Based Therapies

Mortality Trumps All: Ticagrelor for (Nearly) All!

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Defining and Measuring Frailty: An Important Assessment Feature of High-Risk TAVR Patients

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Basal Stenosis Resistance Index: Background, Physiologic Rationale, and Clinical Data

Case #1: iFR Case

A Patient with a Recent Stent Who is Bleeding

How New Designs Lead to Improved Clinical Results in TAVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content